Andrew Holden
Overview
Explore the profile of Andrew Holden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
820
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dean A, Hassan S, Yasutomi M, Holden A, Hill A
Ann Vasc Surg
. 2025 Mar;
PMID: 40081528
Background: Aortic sac expansion after endovascular aortic aneurysm repair (EVAR) is associated with higher re-intervention rates, late rupture, and long-term all-cause mortality. Endovascular options have limitations, and guidelines recommend open...
2.
Brodmann M, Gray W, Schneider P, Kurzmann-Guetl K, Schweiger L, Zeller T, et al.
Eur J Vasc Endovasc Surg
. 2024 Nov;
69(3):452-462.
PMID: 39615582
Objective: The aim of the TRANSCEND study was to compare the safety and efficacy of the next generation SurVeil PCB with the IN.PACT Admiral PCB in patients with femoropopliteal arterial...
3.
Corl J, Clair D, Mwipatayi P, Khashram M, Shammas N, Soukas P, et al.
JACC Cardiovasc Interv
. 2024 Nov;
18(3):398-399.
PMID: 39545890
No abstract available.
4.
Armstrong E, Adams G, Soukas P, Mangalmurti S, Shammas N, Mehrle A, et al.
J Endovasc Ther
. 2024 Oct;
:15266028241283716.
PMID: 39422234
Purpose: Intravascular lithotripsy (IVL) has shown promising safety and effectiveness in calcified peripheral artery disease (PAD) in large trials and small real-world experiences. Real-world evidence from a larger cohort is...
5.
Zeller T, Zhang Z, Parise H, Mascho C, Holden A, Schmidt A, et al.
J Endovasc Ther
. 2024 Sep;
:15266028241280685.
PMID: 39305087
Purpose: Vessel recoil is a common phenomenon occurring in the tibial vessels following balloon angioplasty. This study examined the occurrence and short-term impact of acute vessel recoil in a subset...
6.
Tepe G, Brodmann M, Bachinsky W, Holden A, Zeller T, Mangalmurti S, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(4):100341.
PMID: 39131928
Background: Endovascular treatment of calcified peripheral artery lesions may be associated with suboptimal vessel expansion, increased complication risk, and reduced long-term patency. The primary endpoint from the Disrupt PAD III...
7.
Lyden S, Brodmann M, Schroeder H, Holden A, Ouriel K, Tarra T, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(4):100634.
PMID: 39131660
Background: There is a need to evaluate the latest information regarding a potential late safety signal in patients treated with paclitaxel-coated devices for peripheral artery disease. We evaluated the 5-year...
8.
Krishnan P, Faries P, Niazi K, Sachar R, Jain A, Brodmann M, et al.
Am J Cardiol
. 2024 Jul;
227:83-90.
PMID: 39019203
This study aimed to report the 5-year outcomes from the ILLUMENATE Pivotal randomized controlled trial of the lower dose (2 µg/mm) Stellarex drug-coated balloon (DCB) (Philips, formerly Spectranetics Corp, Colorado...
9.
Abraham R, Arepally A, Liu D, Lewandowski R, Kappadath S, Verma A, et al.
J Vasc Interv Radiol
. 2024 Jun;
35(10):1464-1473.e1.
PMID: 38944236
Purpose: To determine 6-month interim safety, effectiveness, and multimodal imageability of imageable glass microsphere yttrium-90 (Y) radioembolization for unresectable hepatocellular carcinoma (HCC) in a first-in-human trial. Materials And Methods: Imageable...
10.
Patrone L, Pasqui E, Conte M, Farber A, Ferraresi R, Menard M, et al.
J Endovasc Ther
. 2024 Mar;
:15266028241231745.
PMID: 38523459
No abstract available.